05:58 PM EDT, 08/14/2026 (MT Newswires) -- Paul T Quinlan, General Counsel, on August 14, 2026, sold 52,000 shares in Oruka Therapeutics ( ORKA ) for $5,641,409. Following the Form 4 filing with the SEC, Quinlan has control over a total of 31,034 common shares of the company, with 31,034 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/907654/000090765426000077/xslF345X05/form4.xml